Tennessee 2025-2026 Regular Session

Tennessee House Bill HB2136

Introduced
2/2/26  
Refer
2/27/26  
Refer
3/11/26  
Refer
3/31/26  
Refer
4/7/26  
Engrossed
4/16/26  

Caption

AN ACT to amend Tennessee Code Annotated, Title 39; Title 53; Title 63 and Title 68, relative to medications approved by the federal food and drug administration.

Impact

The implications of HB 2136 are significant for both healthcare providers and patients in Tennessee. By allowing healthcare prescribers to prescribe newly scheduled drugs immediately upon their FDA approval—rather than waiting for additional state-level actions—the bill enhances the accessibility of medications. This aligns state law with federal regulations, promoting a more coordinated drug management process and potentially improving health outcomes through quicker access to effective treatments.

Summary

House Bill 2136 is an act designed to amend several titles of the Tennessee Code Annotated relating to medications approved by the federal Food and Drug Administration (FDA). The bill introduces provisions that will allow certain drug products, once they have been scheduled by the FDA, to be prescribed by healthcare providers without unnecessary delays. This initiative aims to streamline the process of integrating new drug approvals into state law and ensure that approved medications can reach patients quickly and efficiently.

Sentiment

The sentiment surrounding HB 2136 appears to be positive, reflecting a consensus among lawmakers about the necessity of reducing bureaucratic hurdles in drug prescription processes. The bill received unanimous support in the voting session, indicating that legislators recognize the importance of facilitating timely access to medications for patients while also adhering to safety protocols established at the federal level.

Contention

While the bill has garnered substantial support, it may still encounter concerns regarding the oversight of prescribed medications. Some stakeholders could argue that allowing immediate prescriptions upon FDA scheduling may bypass critical local review processes. However, such concerns seem minimal within the current discussions as the focus remains on harmonizing state laws with federal standards, ensuring healthcare providers can respond effectively to the needs of their patients without significant delays.

Companion Bills

TN SB2556

Crossfiled AN ACT to amend Tennessee Code Annotated, Title 39; Title 53; Title 63 and Title 68, relative to medications approved by the federal food and drug administration.

Previously Filed As

TN SB2556

AN ACT to amend Tennessee Code Annotated, Title 39; Title 53; Title 63 and Title 68, relative to medications approved by the federal food and drug administration.

TN HB2173

AN ACT to amend Tennessee Code Annotated, Title 47; Title 53; Title 56; Title 63 and Title 68, relative to medications approved by the federal food and drug administration.

TN SB2437

AN ACT to amend Tennessee Code Annotated, Title 47; Title 53; Title 56; Title 63 and Title 68, relative to medications approved by the federal food and drug administration.

TN SB1146

AN ACT to amend Tennessee Code Annotated, Title 38; Title 53; Title 63 and Title 68, relative to psychotropic drugs.

TN HB1349

AN ACT to amend Tennessee Code Annotated, Title 38; Title 53; Title 63 and Title 68, relative to psychotropic drugs.

TN HB1260

AN ACT to amend Tennessee Code Annotated, Title 8; Title 33; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to prescription drugs.

TN SB1256

AN ACT to amend Tennessee Code Annotated, Title 8; Title 33; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to prescription drugs.

TN HB0037

AN ACT to amend Tennessee Code Annotated, Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to the use of drugs for the treatment of pain.

TN SB0428

AN ACT to amend Tennessee Code Annotated, Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to the use of drugs for the treatment of pain.

TN HB1741

AN ACT to amend Tennessee Code Annotated, Title 8; Title 41; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to the use of drugs for the treatment of pain.

Similar Bills

No similar bills found.